Bailard, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $220,471 - $303,189	-1,714 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $228,294 - $316,242	-1,800 Reduced 51.22%	1,714 $242,000
Q4 2020 Feb 03, 2021	BUY	$122.97 - $147.0 $1,721 - $2,058	14 Added 0.4%	3,514 $457,000
Q1 2019 Apr 24, 2019	BUY	$72.76 - $93.45 $254,660 - $327,075	3,500 New	3,500 $327,000
Q1 2018 May 07, 2018	SELL	$115.92 - $148.54 $405,720 - $519,890	-3,500 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$114.49 - $139.98 $400,715 - $489,929	3,500	3,500 $0

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.